Acuity Brands INC ACUITY BRANDS O.../ US00508Y1029 /
8/23/2021 12:00:00 AM | Chg. - | Volume | Bid6:00:03 AM | Ask6:00:03 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
182.48USD | - | 2 Turnover: - |
-Bid Size: - | -Ask Size: - | 8 bill.USD | 0.20% | 23.86 |
GlobeNewswire
5/30
Newton Golf Shafts Introduces a Weekly Motion Driver Performance Pool Program for PGA TOUR Champions...
GlobeNewswire
5/29
AREX Capital Management Issues Letter to Enhabit Stockholders Regarding the Need for Dramatic Change...
GlobeNewswire
5/28
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
GlobeNewswire
5/21
Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients w...
GlobeNewswire
5/15
Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
GlobeNewswire
5/15
Wondr Health and Solera Health Partner to Provide Expert Weight and Obesity-Management Solution for ...
GlobeNewswire
5/14
Parity Healthcare Analytics, Maine RMOMS Network launch program to support state’s obstetrical units
GlobeNewswire
5/14
Western University’s Faculty of Engineering Embraces Holistic Admissions with Acuity Insights’ Caspe...
GlobeNewswire
5/14
Newton Golf Shafts Helps Propel Doug Barron to His First Major Championship on the PGA TOUR Champion...
GlobeNewswire
5/14
Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
5/13
Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
GlobeNewswire
5/10
Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update
GlobeNewswire
5/9
Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
5/8
Oculis Announces Completion of Enrollment in Phase 2 Randomized Controlled ACUITY Trial with OCS-05 ...
GlobeNewswire
5/8
LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
5/8
Clene Reports First Quarter 2024 Financial Results and Recent Operating Highlights
GlobeNewswire
5/7
Annexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Struc...
GlobeNewswire
5/7
EyeDNA Therapeutics Announces Positive 24-month Data Presented at ARVO from Ongoing Phase I/II Trial...